Article
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
11 Apr 2018
Abstract excerpt
BACKGROUND: Robust and precise molecular prognostic predictors for luminal breast cancer are required. This study aimed to identify key methylation sites in luminal breast cancer, as well as precise molecular tools for predicting prognosis. METHODS: We compared methylation levels of normal and luminal breast cancer samples from The Cancer Genome Atlas dataset. The relationships among differentially methylated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
